Health7 hours ago
Merck and Eisai’s Keytruda-Lenvima Combo Fails Liver Cancer Trial
Merck & Co. and Eisai Co., Ltd. announced disappointing results from their late-stage clinical trial investigating the combination of Keytruda, an immunotherapy, and Lenvima, a targeted...